IDE1 is primarily used in research and development within the field of regenerative medicine and stem cell biology. It is known for its ability to induce differentiation of stem cells into insulin-producing cells, making it a valuable tool in studies aimed at developing treatments for diabetes. Researchers utilize IDE1 to explore mechanisms of cell differentiation and to generate pancreatic beta cells in vitro, which can be further studied for potential therapeutic applications. Its role in enhancing the efficiency of stem cell differentiation also contributes to advancements in tissue engineering and cell-based therapies.